netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Prednisolone found 18 matches

Formulary items 14 matches
Non-formulary items 1 match
   
Open monograph to display formulary status BNF Category
  MethylPrednisolone Acetate 40mg in 1ml injection Musculoskeletal and joint diseases - Local corticosteroids injections - 10.01.02.02
  MethylPrednisolone Acetate 40mg with lidocaine 1% injection Musculoskeletal and joint diseases - Local corticosteroids injections - 10.01.02.02
  MethylPrednisolone Acetate 40mgin 1ml and 120mg in 3ml (depot)
(injection) 		Endocrine system - Glucocorticoid therapy - 06.03.02
  MethylPrednisolone sodium succinate 2mg, 4mg, and 16mg  (tablets) Endocrine system - Glucocorticoid therapy - 06.03.02
  MethylPrednisolone sodium succinate 40mg, 125mg, 500mg & 1000mg  (injection) Endocrine system - Glucocorticoid therapy - 06.03.02
  Prednisolone
(Rectal Preparations) 		Gastro-intestinal system - Corticosteroids - 01.05.02
  Prednisolone
(Oral Preparations) 		Gastro-intestinal system - Corticosteroids - 01.05.02
  Prednisolone Endocrine system - Glucocorticoid therapy - 06.03.02
  Prednisolone 0.5% ear/eye drops Ear, nose and oropharynx - Anti-inflammatory preparations - 12.01.01
  Prednisolone 0.5% Single Use Minims® Eye - Corticosteroids - 11.04.01
  Prednisolone eye drops Eye - Corticosteroids - 11.04.01
  Hydrocortisone modified-release capsules  (Efmody®) Endocrine system - Glucocorticoid therapy - 06.03.02
  Polatuzumab vedotin  (Polivy®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Scheriproct®
(Ointment / Suppositories) 		Gastro-intestinal system - Compound haemorrhoidal preparations with corticosteroids - 01.07.02
 
Non Formulary BNF Category
  Prednisolone
(1mg gastro-resistant tablet) 		Gastro-intestinal system - Corticosteroids - 01.05.02


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Alert (Oct 2017): Methylprednisolone injectable medicine containing lactose (Solu-Medrone 40 mg): do not use in patients with cows’ milk allergy  (06.03.02)
link in drug section MHRA Drug Safety Update (December 2017): Radium-223 dichloride (Xofigo▼): do not use in combination with abiraterone and prednisone/prednisolone, following clinical trial signal of increased risk of death and fractures   (08.03.04.02)
link in subsection North of Tyne, Gateshead and North Cumbria - Prednisolone Shared Care Agreement (Renal Transplant) (08.02.02)


 
netFormulary